phosphorylcholine has been researched along with resveratrol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Gajate, C; Mollinedo, F; Reis-Sobreiro, M | 1 |
Alvarez-Lorenzo, C; Carracedo, G; Concheiro, A; Huete-Toral, F; Otero, A; Parga, A; Pereira-da-Mota, AF; Vivero-Lopez, M | 1 |
2 other study(ies) available for phosphorylcholine and resveratrol
Article | Year |
---|---|
Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions.
Topics: Antineoplastic Agents; Apoptosis; bcl-X Protein; BH3 Interacting Domain Death Agonist Protein; Boronic Acids; Bortezomib; Caspase 10; Caspase 8; Cell Line, Tumor; Drug Synergism; fas Receptor; Fas-Associated Death Domain Protein; Flow Cytometry; Fluorescent Antibody Technique; Humans; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Leukemia, T-Cell; Membrane Microdomains; Microscopy, Confocal; Mitochondria; Multiple Myeloma; Phosphorylcholine; Pyrazines; Resveratrol; Signal Transduction; Stilbenes | 2009 |
Phosphorylcholine-Based Contact Lenses for Sustained Release of Resveratrol: Design, Antioxidant and Antimicrobial Performances, and
Topics: Animals; Anti-Infective Agents; Antioxidants; Contact Lenses; Delayed-Action Preparations; Hydrogels; Phosphorylcholine; Rabbits; Resveratrol; Staphylococcus aureus; Tissue Distribution; Water | 2022 |